Kallyope and Sosei Heptares Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery Portfolio News / By Karina Tin May 17th, 2022 Kallyope and Sosei Heptares Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery Read More »
Remix Therapeutics Closes $70 Million Series B Financing Portfolio News / By Karina Tin May 17, 2022 Remix Therapeutics Closes $70 Million Series B Financing Read More »
Surrozen Publishes Article in Cellular and Molecular Gastroenterology and Hepatology Demonstrating that SZN-1326, a Selective Wnt Mimetic, Stimulated Robust Colon Epithelial Regeneration and Ameliorated Colitis in an Acute Model of Inflammatory Bowel Disease Portfolio News / By Karina Tin May 16, 2022 Surrozen Publishes Article in Cellular and Molecular Gastroenterology and Hepatology Demonstrating that SZN-1326, a Selective Wnt Mimetic, Stimulated Robust Colon Epithelial Regeneration and Ameliorated Colitis in an Acute Model of Inflammatory Bowel Disease Read More »
NGM Bio Announces Initiation of Phase 1/1b Clinical Study of NGM438 for the Treatment of Patients with Advanced Solid Tumors Portfolio News / By Karina Tin May 12, 2022 NGM Bio Announces Initiation of Phase 1/1b Clinical Study of NGM438 for the Treatment of Patients with Advanced Solid Tumors Read More »
Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update Portfolio News / By Karina Tin May 11, 2022 Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update Read More »
RAPT Therapeutics Reports First Quarter 2022 Financial Results Portfolio News / By Karina Tin May 11, 2022 RAPT Therapeutics Reports First Quarter 2022 Financial Results Read More »
Surrozen Reports First Quarter 2022 Financial Results Portfolio News / By Karina Tin May 11, 2022 Surrozen Reports First Quarter 2022 Financial Results Read More »
eFFECTOR Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update Portfolio News / By Karina Tin May 10, 2022 eFFECTOR Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update Read More »
Nurix Therapeutics to Host R&D Day on May 26, 2022 Portfolio News / By Karina Tin May 9, 2022 Nurix Therapeutics to Host R&D Day on May 26, 2022 Read More »
ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update Portfolio News / By Karina Tin May 9, 2022 ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update Read More »
